VITA 34 International records strong growth in 1st quarter of 2007 – Contracts concluded 90 percent up / EBIT balanced despite growth investments

Vita 34 International AG / Quarter Results

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

Leipzig, April 2, 2007 – Preliminary figures show that VITA 34
International AG (ISIN DE000A0BL849), parent company of VITA 34, the
leading private umbilical cord blood bank in the German-speaking countries,
continued to accelerate its growth in the first quarter of 2007. As regards
ongoing business, revenues according to IFRS were up 40 percent, rising
from 2.5 million Euro during the comparative period last year to 3.5
million Euro. The number of contracts concluded rose even more sharply;
these precede future revenues by a period of several months. With 2,746 new
contracts for the storage of cord blood, the comparative figure from the
previous year (1,447) was exceeded by 90 percent; this is the highest
figure ever achieved in the company’s history to date.

The number of transplants stored rose by 83 percent to 2,446, another
record level. This proves that the first measures of the newly implemented
marketing and distribution strategy are already taking positive effect.

Despite investments associated with the growth strategy, EBIT results were
balanced in the 1st quarter of 2007. The executive board of VITA 34
International AG sees the very positive developments during the quarter as
confirmation of its growth expectations for the entire year. In future, the
company will expand the distribution and marketing areas even further,
using the inflow of funds from the stock market flotation in order the
accelerate the increase in market potential for cord blood banking in

Press/Investor Relations: 
Axel Mühlhaus
Dr. Sönke Knop
edicto GmbH
Zeisselstraße 19
D-60318 Frankfurt
Tel.: +49 (069) 90550552
Fax: +49 (069) 90550577

DGAP 02.04.2007 
Language:     English
Issuer:       Vita 34 International AG
              Deutscher Platz 5a
              04103 Leipzig Deutschland
Phone:        +49(0341)48792-40
Fax:          +49(0341)48792-39
ISIN:         DE000A0BL849
WKN:          A0BL84
Listed:       Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin-Bremen, Düsseldorf, Hamburg, München, Stuttgart
End of News                                     DGAP News-Service